nach oben

Journal of Cancer Survivorship

Erschienen in:

01.03.2011 | Erratum

Erratum to: The impact of diabetes process and outcome quality measures on overall survival in patients with co-morbid colorectal cancer

verfasst von: Elizabeth Y. Chiao, Preethi V. Nimbi, Aanand D. Naik

Erschienen in: Journal of Cancer Survivorship | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Excerpt

Erratum to: J Cancer Surviv …

American Cancer Society. Colorectal cancer facts and figures 2008–2010. 2009.

Gross CP. Multimorbidity and survival in older persons with colorectal cancer. J Am Geriatr Soc. 2006;54(12):1898–904.CrossRefPubMed

Yancik R. Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study. Cancer. 1998;82(11):2123–34.CrossRefPubMed

Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ et al. SEER Cancer Statistics Review, 1975–2005. 2007.

Williams JC. Colon carcinoma and diabetes mellitus. Cancer. 1984;54(12):3070–1.CrossRefPubMed

O’Mara BA. Diabetes mellitus and cancer risk: a multisite case-control study. J Chron Dis. 1985;38(5):435–41.CrossRefPubMed

La VC. Diabetes mellitus and colorectal cancer risk. Cancer Epidemiol Biomark Prev. 1997;6(12):1007–10.

La VC. History of selected diseases and the risk of colorectal cancer. Eur J Cancer. 1991;27(5):582–6.CrossRef

Nilsen TI. Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis. Br J Cancer. 2001;84(3):417–22.CrossRefPubMed

10.

Meyerhardt JA. Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol. 2003;21(3):433–40.CrossRefPubMed

11.

Barone BB, Yeh HC, Snyder CF, et al. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA. 2008;300:2754–64.CrossRefPubMed

12.

Siddiqui AA. Elevated HbA1c is an independent predictor of aggressive clinical behavior in patients with colorectal cancer: a case-control study. Dig Dis Sci. 2008;53(9):286–94.

13.

Keating NL. Quality of diabetes care among cancer survivors with diabetes. Med Care. 2007;45(9):869–75.CrossRefPubMed

14.

Wattacheril J. Lagtimes in diagnosis and treatment of colorectal cancer: determinants and association with cancer stage and survival. Aliment Pharmacol Ther. 2008;28(9):1166–74.CrossRefPubMed

15.

Deyo RA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613–19.CrossRefPubMed

16.

Arnold N, Sohn M, Maynard C, Hynes DM. VIReC technical Report 2: VANDI Mortality Data Merge Project. 4-9-2006.

17.

El-Serag HB. Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes. Gastroenterology. 2009;136(5):1601–8.CrossRefPubMed

18.

Polednak AP. Comorbid diabetes mellitus and risk of death after diagnosis of colorectal cancer: a population-based study. Cancer Detect Prev. 2006;30(5):466–72.CrossRefPubMed

19.

Shonka NA. Effect of diabetes mellitus on the epidemiology and outcomes of colon cancer. Med Oncol. 2006;23(4):515–19.CrossRefPubMed

20.

Kerr EA. Making performance indicators work: experiences of US Veterans Health Administration. BMJ. 2007;335(7627):971–3.CrossRefPubMed

21.

Jha AK. Effect of the transformation of the Veterans Affairs Health Care System on the quality of care. N Engl J Med. 2003;348(22):2218–27.CrossRefPubMed

22.

Nattinger AB. Geographic variation in the use of breast-conserving treatment for breast cancer. N Engl J Med. 1992;326(17):1102–7.CrossRefPubMed

Titel: Erratum to: The impact of diabetes process and outcome quality measures on overall survival in patients with co-morbid colorectal cancer
verfasst von: Elizabeth Y. Chiao
Preethi V. Nimbi
Aanand D. Naik
Publikationsdatum: 01.03.2011
Verlag: Springer US
Erschienen in: Journal of Cancer Survivorship / Ausgabe 1/2011
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI: https://doi.org/10.1007/s11764-010-0158-2

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Erratum to: The impact of diabetes process and outcome quality measures on overall survival in patients with co-morbid colorectal cancer

Excerpt

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2011

Do ongoing lifestyle disruptions differ across cancer types after the conclusion of cancer treatment?

Physical activity type and intensity among rural breast cancer survivors: patterns and associations with fatigue and depressive symptoms

Engaging African American breast cancer survivors in an intervention trial: culture, responsiveness and community

Physical activity and health-related quality of life in young adult cancer survivors: a Canadian provincial survey

Racial/ethnic differences in job loss for women with breast cancer

Erratum to: An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie